Christoffer Clemmensen

Christoffer Clemmensen

Auto-generated profile, based on publicly available information

Christoffer Clemmensen

Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2014 in Nature
Verified
Journal Article
Open access
PDF file
KRKaren Ryan
Karen Ryan
VTValentina Tremaroli
Valentina Tremaroli
CCChristoffer Clemmensen
Christoffer Clemmensen
PKPetia Kovatcheva-Datchary
Petia Kovatcheva-Datchary
AMAndriy Myronovych
Andriy Myronovych
RSRandy J. Seeley
Randy J. Seeley
Bariatric surgical procedures, such as vertical sleeve gastrectomy (VSG), are at present the most effective therapy for the treatment of obesity, and are associated with considerable improvements in co-morbidities, including type-2 diabetes mellitus. The underlying molecular mechanisms contributing to these benefits remain largely undetermined, despite offering the potential to reveal new targets for therapeutic intervention. Substantial changes in circulating total bile acids are known to occur after VSG. Moreover, bile acids are known to regulate metabolism by binding to the nuclear receptor FXR (farsenoid-X receptor, also known as NR1H4). We therefore examined the results of VSG surgery applied to mice with diet-induced obesity and targeted genetic disruption of FXR. Here we demonstrate that the therapeutic value of VSG does not result from mechanical restriction imposed by a smaller stomach. Rather, VSG is associated with increased circulating bile acids, and associated changes to gut microbial communities. Moreover, in the absence of FXR, the ability of VSG to reduce body weight and improve glucose tolerance is substantially reduced. These results point to bile acids and FXR signalling as an important molecular underpinning for the beneficial effects of this weight-loss surgery.

19 January 2018 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
MKMaximilian Kleinert
Maximilian Kleinert
CCChristoffer Clemmensen
Christoffer Clemmensen
SHSusanna M. Hofmann
Susanna M. Hofmann
MMMary C. Moore
Mary C. Moore
SRSimone Renner
Simone Renner
MTMatthias H. Tschöp
Matthias H. Tschöp

7 July 2010 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
AKAnders B. Klein
Anders B. Klein
RWRebecca Williamson
Rebecca Williamson
MSMartin A. Santini
Martin A. Santini
CCChristoffer Clemmensen
Christoffer Clemmensen
AEAnders Ettrup
Anders Ettrup
SASusana Aznar
Susana Aznar
Brain-derived neurotrophic factor (BDNF) is involved in synaptic plasticity, neuronal differentiation and survival of neurons. Observations of decreas

8 December 2014 in Nature Medicine
Verified
Journal Article
Closed access
BFBrian Finan
Brian Finan
BYBin Yang
Bin Yang
NONickki Ottaway
Nickki Ottaway
DSDavid L Smiley
David L Smiley
TMTao Ma
Tao Ma
MTMatthias H Tschöp
Matthias H Tschöp

1 April 2017 in Physiological Reviews
Verified
Journal Article
Open access
PDF file
TMT. D. Müller
T. D. Müller
BFB. Finan
B. Finan
CCC. Clemmensen
C. Clemmensen
RDR. D. DiMarchi
R. D. DiMarchi
MTM. H. Tschöp
M. H. Tschöp
In the last two decades we have witnessed sizable progress in defining the role of gastrointestinal signals in the control of glucose and energy homeostasis. Specifically, the molecular basis of the huge metabolic benefits in bariatric surgery is emerging while novel incretin-based medicines based on endogenous hormones such as glucagon-like peptide 1 and pancreas-derived amylin are improving diabetes management. These and related developments have fostered the discovery of novel insights into endocrine control of systemic metabolism, and in particular a deeper understanding of the importance of communication across vital organs, and specifically the gut-brain-pancreas-liver network. Paradoxically, the pancreatic peptide glucagon has reemerged in this period among a plethora of newly identified metabolic macromolecules, and new data complement and challenge its historical position as a gut hormone involved in metabolic control. The synthesis of glucagon analogs that are biophysically stable and soluble in aqueous solutions has promoted biological study that has enriched our understanding of glucagon biology and ironically recruited glucagon agonism as a central element to lower body weight in the treatment of metabolic disease. This review summarizes the extensive historical record and the more recent provocative direction that integrates the prominent role of glucagon in glucose elevation with its under-acknowledged effects on lipids, body weight, and vascular health that have implications for the pathophysiology of metabolic diseases, and the emergence of precision medicines to treat metabolic diseases.

17 April 2017 in Nature Medicine
Verified
Journal Article
Open access
PDF file
KFKatrin Fischer
Katrin Fischer
HRHenry H Ruiz
Henry H Ruiz
KJKevin Jhun
Kevin Jhun
BFBrian Finan
Brian Finan
DODouglas J Oberlin
Douglas J Oberlin
CBChristoph Buettner
Christoph Buettner
In contrast to previously reported findings, M2-like polarized macrophages are not a source of catecholamines and do not contribute to browning of the fat. Adaptive thermogenesis is the process of heat generation in response to cold stimulation. It is under the control of the sympathetic nervous system, whose chief effector is the catecholamine norepinephrine (NE). NE enhances thermogenesis through β3-adrenergic receptors to activate brown adipose tissue and by 'browning' white adipose tissue. Recent studies have reported that alternative activation of macrophages in response to interleukin (IL)-4 stimulation induces the expression of tyrosine hydroxylase (TH), a key enzyme in the catecholamine synthesis pathway, and that this activation provides an alternative source of locally produced catecholamines during the thermogenic process. Here we report that the deletion of Th in hematopoietic cells of adult mice neither alters energy expenditure upon cold exposure nor reduces browning in inguinal adipose tissue. Bone marrow–derived macrophages did not release NE in response to stimulation with IL-4, and conditioned media from IL-4-stimulated macrophages failed to induce expression of thermogenic genes, such as uncoupling protein 1 (Ucp1), in adipocytes cultured with the conditioned media. Furthermore, chronic treatment with IL-4 failed to increase energy expenditure in wild-type, Ucp1−/− and interleukin-4 receptor-α double-negative (Il4ra−/−) mice. In agreement with these findings, adipose-tissue-resident macrophages did not express TH. Thus, we conclude that alternatively activated macrophages do not synthesize relevant amounts of catecholamines, and hence, are not likely to have a direct role in adipocyte metabolism or adaptive thermogenesis.